Reducing thrombus burden would improve patient’s outcomes. Low-dose intracoronary thrombolytic agent administration has been considered to improve myocardial microcirculation, cardiac function, and major adverse cardiovascular events in patients presenting with ST-segment elevation myocardial infarction and high thrombus burden. This paper discusses published meta-analyses on intracoronary thrombolysis in primary percutaneous intervention.
PellicciaFNiccoliG. Low-dose fibrinolysis during primary percutaneous intervention for preventing no-reflow: stepping back to move forward?EuroIntervention. 2022;18:452-455.
2.
ChenLShiLTianWZhaoS. Intracoronary Thrombolysis in Patients With ST-Segment Elevation Myocardial Infarction: A Meta-Analysis of Randomized Controlled Trials. Angiology. 2021;72:679-686.
3.
KaddouraRMohamed IbrahimMIAl-BadriyehD, et al.Intracoronary pharmacological therapy versus aspiration thrombectomy in STEMI (IPAT-STEMI): A systematic review and meta-analysis of randomized trials. PLoS One. 2022;17:e0263270.
4.
FuYGuXSHaoGZ, et al.Comparison of myocardial microcirculatory perfusion after catheter-administered intracoronary thrombolysis with anisodamine versus standard thrombus aspiration in patients with ST-elevation myocardial infarction. Catheter Cardiovasc Interv. 2019;93(S1):839-845.
5.
WangXLiuHWuH, et al.Safety and efficacy of intracoronary prourokinase administration in patients with high thrombus burden. Coron Artery Dis. 2020;31:493-499.
6.
GrecoCPellicciaFTanzilliG, et al.Usefulness of local delivery of thrombolytics before thrombectomy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (the delivery of thrombolytics before thrombectomy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention [DISSOLUTION] randomized trial). Am J Cardiol. 2013;112:630-635.
